GITNUXREPORT 2025

Diabetic Retinopathy Statistics

Early detection reduces blindness risk in diabetics significantly worldwide.

Jannik Linder

Co-Founder of Gitnux, specialized in content and tech since 2016.

First published: April 29, 2025

Our Commitment to Accuracy

Rigorous fact-checking • Reputable sources • Regular updatesLearn more

Statistic 1

Early detection and treatment of diabetic retinopathy can prevent up to 95% of blindness cases caused by the disease

Statistic 2

Regular retinal screenings can reduce the risk of severe vision loss by detecting diabetic retinopathy early

Statistic 3

In the US, annual screening for diabetic retinopathy is recommended at least once every year for diabetics, but adherence rates are less than 70%, affecting early detection

Statistic 4

Diabetic retinopathy is the leading cause of blindness among working-age adults worldwide

Statistic 5

Approximately one-third of people with diabetes have signs of diabetic retinopathy

Statistic 6

The global prevalence of diabetic retinopathy among diabetics is estimated at 35%

Statistic 7

Diabetic retinopathy affects nearly 93 million people worldwide

Statistic 8

In the United States, diabetic retinopathy accounts for 12.3% of new blindness cases

Statistic 9

About 4.8 million Americans aged 40 years and older suffer from diabetic retinopathy

Statistic 10

Diabetic retinopathy is asymptomatic in its early stages in approximately 80% of cases

Statistic 11

At least 15% of diabetics have sight-threatening diabetic retinopathy

Statistic 12

Diabetic retinopathy accounts for approximately 4.8% of global cases of blindness

Statistic 13

The prevalence of diabetic retinopathy in people with type 2 diabetes varies from 20% to 45%, depending on the population studied

Statistic 14

Sight-threatening diabetic retinopathy affects about 10% of diabetics worldwide

Statistic 15

Diabetic retinopathy prevalence increases significantly with age, especially after age 40

Statistic 16

Nearly 24,000 Americans became blind from diabetic retinopathy in 2018

Statistic 17

In low- and middle-income countries, access to diabetic retinopathy screening and treatment is limited, leading to higher rates of blindness

Statistic 18

Diabetic retinopathy is more prevalent among males than females globally, though the difference is small

Statistic 19

Approximately 25% of diabetic patients with retinopathy show signs of diabetic macular edema, which can threaten central vision

Statistic 20

Diabetic retinopathy screening programs have demonstrated cost-effectiveness by preventing vision loss, particularly in high-risk populations

Statistic 21

In patients with diabetes duration over 10 years, the prevalence of diabetic retinopathy approaches 80%

Statistic 22

Up to 30% of patients with diabetic retinopathy also develop diabetic nephropathy, indicating common microvascular damage

Statistic 23

The World Health Organization estimates that diabetic retinopathy accounts for about 2% of all cases of blindness globally

Statistic 24

After 5 years of diabetes, nearly 50% of patients show signs of diabetic retinopathy, emphasizing the importance of early screening

Statistic 25

About 17% of patients with diabetic retinopathy are asymptomatic and unaware of their condition until vision loss occurs

Statistic 26

Diabetic retinopathy prevalence among type 1 diabetics is approximately 90% after 30 years of disease duration

Statistic 27

Approximately 6 million people worldwide are blind due to diabetic retinopathy, and numbers are expected to grow with rising diabetes prevalence

Statistic 28

Diabetic retinopathy is responsible for approximately 5% of all cases of blindness worldwide, a significant contributor to global visual impairment

Statistic 29

The rate of diabetic retinopathy in adolescents with type 1 diabetes has increased over the past decade, correlating with increased obesity and poor glycemic control

Statistic 30

The median age of onset for vision-threatening diabetic retinopathy is approximately 52 years, correlating with long disease duration

Statistic 31

There is a higher prevalence of diabetic retinopathy among minority populations, including African Americans and Hispanics, compared to Caucasians, due to socioeconomic disparities

Statistic 32

Nearly 86% of diabetics aged 40 years and above in low- and middle-income countries are not receiving diabetic retinopathy screening and treatment, leading to preventable blindness

Statistic 33

The risk of developing diabetic retinopathy increases with the duration of diabetes, with nearly all type 1 diabetics developing it after 20 years

Statistic 34

Poor blood sugar control significantly increases the risk of diabetic retinopathy progression

Statistic 35

The progression of diabetic retinopathy can be slowed down with good blood pressure control

Statistic 36

Nearly 50% of diabetics with poor glycemic control develop diabetic retinopathy within 10 years of diagnosis

Statistic 37

Pregnant women with pre-existing diabetes are at increased risk of developing diabetic retinopathy during pregnancy, with some studies showing up to 40% incidence

Statistic 38

The incidence of diabetic retinopathy is higher among individuals with co-existing hypertension, due to microvascular damage

Statistic 39

The quality of glycemic control directly correlates with the incidence of diabetic retinopathy, with worse control leading to higher prevalence

Statistic 40

The risk of diabetic retinopathy increases fivefold in patients with uncontrolled hypertension, compared to those with normal blood pressure

Statistic 41

People with longer duration of diabetes are more likely to develop proliferative diabetic retinopathy compared to non-proliferative forms

Statistic 42

Diabetic retinopathy can be prevented or delayed with early lifestyle interventions and proper diabetes management, reducing the risk by over 50%

Statistic 43

Studies show a direct relationship between poor lipid control and progression of diabetic retinopathy, highlighting the importance of lipid management

Statistic 44

The cost of managing diabetic retinopathy in the US exceeds $500 million annually, including treatment and productivity loss

Statistic 45

The burden of diabetic retinopathy is disproportionately higher in low-income populations due to limited access to healthcare, leading to greater rates of undiagnosed or untreated cases

Statistic 46

Laser photocoagulation reduces the risk of severe vision loss by about 50% in proliferative diabetic retinopathy cases

Statistic 47

Anti-VEGF therapies have become the standard treatment for diabetic macular edema, a common complication of diabetic retinopathy

Statistic 48

About 30% of diabetics with proliferative diabetic retinopathy retain good vision after laser treatment

Statistic 49

Advanced diabetic retinopathy can lead to vitreous hemorrhage and tractional retinal detachment, often requiring surgical intervention

Statistic 50

Insulin therapy and tight glycemic control have been shown to reduce the incidence of diabetic retinopathy progression by about 50%

Statistic 51

Laser treatment insignificantly reduces vision loss in mild non-proliferative diabetic retinopathy, but is essential in proliferative stages

Statistic 52

The use of intravitreal corticosteroids is an alternative treatment for diabetic macular edema, especially in patients unresponsive to other therapies

Statistic 53

Treatment adherence significantly improves visual outcomes in patients with diabetic retinopathy, emphasizing the need for patient education and follow-up

Slide 1 of 53

Sources

Our Reports have been cited by:

Trust Badges - Publications that have cited our reports

Key Highlights

Diabetic retinopathy is the leading cause of blindness among working-age adults worldwide
Approximately one-third of people with diabetes have signs of diabetic retinopathy
The global prevalence of diabetic retinopathy among diabetics is estimated at 35%
Diabetic retinopathy affects nearly 93 million people worldwide
In the United States, diabetic retinopathy accounts for 12.3% of new blindness cases
About 4.8 million Americans aged 40 years and older suffer from diabetic retinopathy
The risk of developing diabetic retinopathy increases with the duration of diabetes, with nearly all type 1 diabetics developing it after 20 years
Poor blood sugar control significantly increases the risk of diabetic retinopathy progression
Diabetic retinopathy is asymptomatic in its early stages in approximately 80% of cases
At least 15% of diabetics have sight-threatening diabetic retinopathy
Laser photocoagulation reduces the risk of severe vision loss by about 50% in proliferative diabetic retinopathy cases
Anti-VEGF therapies have become the standard treatment for diabetic macular edema, a common complication of diabetic retinopathy
Early detection and treatment of diabetic retinopathy can prevent up to 95% of blindness cases caused by the disease

Diabetic retinopathy, the leading cause of blindness among working-age adults worldwide, affects nearly 93 million people and remains largely preventable through early detection and proper management.

Diagnosis, Screening, and Detection Strategies

Early detection and treatment of diabetic retinopathy can prevent up to 95% of blindness cases caused by the disease
Regular retinal screenings can reduce the risk of severe vision loss by detecting diabetic retinopathy early
In the US, annual screening for diabetic retinopathy is recommended at least once every year for diabetics, but adherence rates are less than 70%, affecting early detection

Diagnosis, Screening, and Detection Strategies Interpretation

Despite the fact that early detection through annual screenings can prevent up to 95% of blindness caused by diabetic retinopathy, less than 70% of diabetics in the US are getting screened yearly—suggesting that awareness and adherence still need serious eye-opening improvements.

Prevalence and Epidemiology of Diabetic Retinopathy

Diabetic retinopathy is the leading cause of blindness among working-age adults worldwide
Approximately one-third of people with diabetes have signs of diabetic retinopathy
The global prevalence of diabetic retinopathy among diabetics is estimated at 35%
Diabetic retinopathy affects nearly 93 million people worldwide
In the United States, diabetic retinopathy accounts for 12.3% of new blindness cases
About 4.8 million Americans aged 40 years and older suffer from diabetic retinopathy
Diabetic retinopathy is asymptomatic in its early stages in approximately 80% of cases
At least 15% of diabetics have sight-threatening diabetic retinopathy
Diabetic retinopathy accounts for approximately 4.8% of global cases of blindness
The prevalence of diabetic retinopathy in people with type 2 diabetes varies from 20% to 45%, depending on the population studied
Sight-threatening diabetic retinopathy affects about 10% of diabetics worldwide
Diabetic retinopathy prevalence increases significantly with age, especially after age 40
Nearly 24,000 Americans became blind from diabetic retinopathy in 2018
In low- and middle-income countries, access to diabetic retinopathy screening and treatment is limited, leading to higher rates of blindness
Diabetic retinopathy is more prevalent among males than females globally, though the difference is small
Approximately 25% of diabetic patients with retinopathy show signs of diabetic macular edema, which can threaten central vision
Diabetic retinopathy screening programs have demonstrated cost-effectiveness by preventing vision loss, particularly in high-risk populations
In patients with diabetes duration over 10 years, the prevalence of diabetic retinopathy approaches 80%
Up to 30% of patients with diabetic retinopathy also develop diabetic nephropathy, indicating common microvascular damage
The World Health Organization estimates that diabetic retinopathy accounts for about 2% of all cases of blindness globally
After 5 years of diabetes, nearly 50% of patients show signs of diabetic retinopathy, emphasizing the importance of early screening
About 17% of patients with diabetic retinopathy are asymptomatic and unaware of their condition until vision loss occurs
Diabetic retinopathy prevalence among type 1 diabetics is approximately 90% after 30 years of disease duration
Approximately 6 million people worldwide are blind due to diabetic retinopathy, and numbers are expected to grow with rising diabetes prevalence
Diabetic retinopathy is responsible for approximately 5% of all cases of blindness worldwide, a significant contributor to global visual impairment
The rate of diabetic retinopathy in adolescents with type 1 diabetes has increased over the past decade, correlating with increased obesity and poor glycemic control
The median age of onset for vision-threatening diabetic retinopathy is approximately 52 years, correlating with long disease duration
There is a higher prevalence of diabetic retinopathy among minority populations, including African Americans and Hispanics, compared to Caucasians, due to socioeconomic disparities
Nearly 86% of diabetics aged 40 years and above in low- and middle-income countries are not receiving diabetic retinopathy screening and treatment, leading to preventable blindness

Prevalence and Epidemiology of Diabetic Retinopathy Interpretation

Diabetic retinopathy, affecting nearly 93 million individuals worldwide and often silent in early stages, underscores that if diabetes is a long-term guest, losing sight is a costly souvenir—highlighting the urgent need for widespread screening and early intervention to prevent a future where preventable blindness becomes an unavoidable epidemic.

Risk Factors and Disease Progression

The risk of developing diabetic retinopathy increases with the duration of diabetes, with nearly all type 1 diabetics developing it after 20 years
Poor blood sugar control significantly increases the risk of diabetic retinopathy progression
The progression of diabetic retinopathy can be slowed down with good blood pressure control
Nearly 50% of diabetics with poor glycemic control develop diabetic retinopathy within 10 years of diagnosis
Pregnant women with pre-existing diabetes are at increased risk of developing diabetic retinopathy during pregnancy, with some studies showing up to 40% incidence
The incidence of diabetic retinopathy is higher among individuals with co-existing hypertension, due to microvascular damage
The quality of glycemic control directly correlates with the incidence of diabetic retinopathy, with worse control leading to higher prevalence
The risk of diabetic retinopathy increases fivefold in patients with uncontrolled hypertension, compared to those with normal blood pressure
People with longer duration of diabetes are more likely to develop proliferative diabetic retinopathy compared to non-proliferative forms
Diabetic retinopathy can be prevented or delayed with early lifestyle interventions and proper diabetes management, reducing the risk by over 50%
Studies show a direct relationship between poor lipid control and progression of diabetic retinopathy, highlighting the importance of lipid management

Risk Factors and Disease Progression Interpretation

Diabetic retinopathy’s progression is a stark reminder that decades of uncontrolled blood sugar, hypertension, and lipid mismanagement not only threaten sight but underscore the urgent need for vigilant, holistic diabetes care—because when it comes to eye health, prevention is truly the best prescription.

Socioeconomic Impact and Global Burden

The cost of managing diabetic retinopathy in the US exceeds $500 million annually, including treatment and productivity loss
The burden of diabetic retinopathy is disproportionately higher in low-income populations due to limited access to healthcare, leading to greater rates of undiagnosed or untreated cases

Socioeconomic Impact and Global Burden Interpretation

With over half a billion dollars annually draining from American pockets and vulnerable populations left in the dark, diabetic retinopathy exemplifies how economic inequality can blur the line between vision and invisibility.

Treatment Options and Management

Laser photocoagulation reduces the risk of severe vision loss by about 50% in proliferative diabetic retinopathy cases
Anti-VEGF therapies have become the standard treatment for diabetic macular edema, a common complication of diabetic retinopathy
About 30% of diabetics with proliferative diabetic retinopathy retain good vision after laser treatment
Advanced diabetic retinopathy can lead to vitreous hemorrhage and tractional retinal detachment, often requiring surgical intervention
Insulin therapy and tight glycemic control have been shown to reduce the incidence of diabetic retinopathy progression by about 50%
Laser treatment insignificantly reduces vision loss in mild non-proliferative diabetic retinopathy, but is essential in proliferative stages
The use of intravitreal corticosteroids is an alternative treatment for diabetic macular edema, especially in patients unresponsive to other therapies
Treatment adherence significantly improves visual outcomes in patients with diabetic retinopathy, emphasizing the need for patient education and follow-up

Treatment Options and Management Interpretation

While laser photocoagulation can halve the risk of severe vision loss and anti-VEGF therapies have become the cornerstone for diabetic macular edema, ultimately, diligent glycemic control and patient adherence remain the most effective tools in preserving sight amid the complex landscape of diabetic retinopathy.